OM:GENI

Stock Analysis Report

Executive Summary

Generic Sweden AB provides consulting and telecommunication services in Sweden.

Snowflake

Fundamentals

Flawless balance sheet with outstanding track record.

Share Price & News

How has Generic Sweden's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GENI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

35.9%

GENI

-1.3%

SE IT

-1.5%

SE Market


1 Year Return

181.8%

GENI

22.7%

SE IT

18.6%

SE Market

Return vs Industry: GENI exceeded the Swedish IT industry which returned 22.7% over the past year.

Return vs Market: GENI exceeded the Swedish Market which returned 18.6% over the past year.


Shareholder returns

GENIIndustryMarket
7 Day35.9%-1.3%-1.5%
30 Day84.7%3.1%0.6%
90 Day95.7%7.1%10.1%
1 Year206.3%181.8%25.2%22.7%23.7%18.6%
3 Year378.1%271.2%48.6%41.5%34.4%13.9%
5 Year667.8%459.4%152.9%124.9%55.1%21.7%

Price Volatility Vs. Market

How volatile is Generic Sweden's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Generic Sweden undervalued compared to its fair value and its price relative to the market?

28.56x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: GENI (SEK19.3) is trading above our estimate of fair value (SEK17.94)

Significantly Below Fair Value: GENI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: GENI is poor value based on its PE Ratio (28.6x) compared to the IT industry average (18.2x).

PE vs Market: GENI is poor value based on its PE Ratio (28.6x) compared to the Swedish market (18.3x).


Price to Earnings Growth Ratio

PEG Ratio: GENI is poor value based on its PEG Ratio (2.3x)


Price to Book Ratio

PB vs Industry: GENI is overvalued based on its PB Ratio (14.8x) compared to the SE IT industry average (3.4x).


Next Steps

Future Growth

How is Generic Sweden forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

12.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GENI's forecast earnings growth (12.4% per year) is above the savings rate (0.4%).

Earnings vs Market: GENI's earnings (12.4% per year) are forecast to grow faster than the Swedish market (9.6% per year).

High Growth Earnings: GENI's earnings are forecast to grow, but not significantly.

Revenue vs Market: GENI's revenue (9% per year) is forecast to grow faster than the Swedish market (4.5% per year).

High Growth Revenue: GENI's revenue (9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GENI's Return on Equity is forecast to be high in 3 years time (33.4%)


Next Steps

Past Performance

How has Generic Sweden performed over the past 5 years?

40.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GENI has high quality earnings.

Growing Profit Margin: GENI's current net profit margins (12.9%) are higher than last year (9.8%).


Past Earnings Growth Analysis

Earnings Trend: GENI has become profitable over the past 5 years, growing earnings by 40.4% per year.

Accelerating Growth: GENI's earnings growth over the past year (48.4%) exceeds its 5-year average (40.4% per year).

Earnings vs Industry: GENI earnings growth over the past year (48.4%) exceeded the IT industry 12.4%.


Return on Equity

High ROE: GENI's Return on Equity (51.8%) is considered outstanding.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Generic Sweden's financial position?


Financial Position Analysis

Short Term Liabilities: GENI's short term assets (SEK28.7M) exceeds its short term liabilities (SEK10.8M)

Long Term Liabilities: GENI's short term assets (SEK28.7M) exceeds its long term liabilities (6.1M)


Debt to Equity History and Analysis

Debt Level: GENI is debt free.

Reducing Debt: GENI had no debt 5 years ago.

Debt Coverage: GENI has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: GENI has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: GENI has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if GENI's debt is covered by short term assets.


Next Steps

Dividend

What is Generic Sweden's current dividend yield, its reliability and sustainability?

1.55%

Current Dividend Yield


Dividend Yield vs Market

company1.6%marketbottom25%1.7%markettop25%4.9%industryaverage2.9%forecastin3Years2.4%

Current dividend yield vs market & industry

Notable Dividend: GENI's dividend (1.55%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.7%).

High Dividend: GENI's dividend (1.55%) is low compared to the top 25% of dividend payers in the Swedish market (4.87%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, GENI has been paying a dividend for less than 10 years.

Growing Dividend: GENI has only been paying a dividend for 4 years, and since then payments have not increased.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (44.4%), GENI's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GENI's dividends in 3 years are forecast to be covered by earnings (56.5% payout ratio).


Next Steps

Management

What is the CEO of Generic Sweden's salary, the management and board of directors tenure and is there insider trading?

10.0yrs

Average board tenure


CEO

Jegerborn Jonas 0

0yrs

Tenure

0

Board Age and Tenure

10.0yrs

Average Tenure

60yo

Average Age

Experienced Board: GENI's board of directors are seasoned and experienced ( 10 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Sellkr895,11019 Jul 19
Fredrik Svedberg
EntityIndividual
Role
Member of the Board of Directors
Owner & Member of the board
Shares108,105
Max Pricekr8.52
Sellkr2,624,37217 Jul 19
Fredrik Svedberg
EntityIndividual
Role
Member of the Board of Directors
Owner & Member of the board
Shares308,484
Max Pricekr8.51
Sellkr3,493,49416 Jul 19
Fredrik Svedberg
EntityIndividual
Role
Member of the Board of Directors
Owner & Member of the board
Shares403,790
Max Pricekr9.01

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Arne Lindberg

    Head Public Relations

    • Tenure: 13.8yrs
  • Fredrik Svedberg (50yo)

    Owner & Member of the board

    • Tenure: 10yrs
    • Compensation: kr1.76m
  • Anders Hansson (66yo)

    CFO, Head of Investor Relations & Head of Finance

    • Tenure: 9.7yrs
  • Patrick Sakurai (48yo)

    Chief Executive Officer of Consultancy Division

    • Tenure: 0yrs
  • Jegerborn Jonas

    Chief Executive Officer

    • Tenure: 0yrs

Board Members

  • Kent-Åke Jönsson (68yo)

    Director

    • Tenure: 10.5yrs
    • Compensation: kr44.00k
  • Hans Krantz (62yo)

    Chairman of the Board

    • Tenure: 10yrs
    • Compensation: kr88.00k
  • Fredrik Svedberg (50yo)

    Owner & Member of the board

    • Tenure: 10yrs
    • Compensation: kr1.76m
  • Stefan Widén (60yo)

    Director

    • Tenure: 0yrs
    • Compensation: kr44.00k
  • Niclas Granholm (57yo)

    Director

    • Tenure: 1.5yrs

Company Information

Generic Sweden AB's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Generic Sweden AB
  • Ticker: GENI
  • Exchange: OM
  • Founded: 1993
  • Industry: IT Consulting and Other Services
  • Sector: Software
  • Market Cap: kr237.236m
  • Shares outstanding: 12.29m
  • Website: https://www.generic.se

Location

  • Generic Sweden AB
  • Hangovagen 18
  • Stockholm
  • Stockholm County
  • 115 41
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GENIOM (OMX Nordic Exchange Stockholm)YesCommon SharesSESEKJan 2007

Biography

Generic Sweden AB provides consulting and telecommunication services in Sweden. The company’s Consultancy division offers high-quality services to clients within the defense and civil security sector, as w ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/21 21:18
End of Day Share Price2019/11/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.